← Leaderboards
Lawrence S Phillips
Emory University
$7,132,519
Attributed
$7,417,519
Total exposure
19
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $981.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,847,519 · 15
CDC$570,000 · 1
AHRQ$0 · 1
VA$0 · 2
By mechanism
R18$2,940,885 · 1
R01$1,703,988 · 2
M01$1,309,101 · 11
T32$573,045 · 1
U18$570,000 · 1
R21$320,500 · 1
Most similar at Emory University
Same institution · by research overlap
- Judith L. Fridovich-Keil$9,505,935
- Nicola Longo$4,081,297
- Kurt Warncke$5,928,812
- Shakira Franco Suglia$12,162,605
- Douglas C Wallace$28,541,550
Others in their field
Top investigators on “Cost”
- Eric S Lander · Whitehead Institute For Biomedical Res$748,368,930
- Richard K. Wilson · Washington University$429,230,873
- Richard A Gibbs · Baylor College Of Medicine$414,258,216
- David R. Weir · University Of Michigan At Ann Arbor$393,741,481
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
Research focus
CostGlucoseDiabetes MellitusComplications Of Diabetes MellitusAdultDosageNon-Insulin-Dependent Diabetes MellitusHypoglycemiaRetinal DiseasesGlycosylated Hemoglobin AHuman SubjectClinical ResearchPredictive ModelingProgramsPharmaceutical PreparationsCaringResourcesRisk FactorsParticipantRaceLife StyleBlood PressureKidneyOutpatients
Grant awards (46)
CHANGING THE NATURAL HISTORY OF TYPE 2 DIABETES â âCHANGEâ STUDY$296,473
R01 · FY2025 · DK · contact PI
Diabetic Complications and Genetic Variants in the Million Veterans Program$0
I01 · FY2025 · VA · contact PI
CHANGING THE NATURAL HISTORY OF TYPE 2 DIABETES â âCHANGEâ STUDY$363,824
R01 · FY2024 · DK · contact PI
Diabetic Complications and Genetic Variants in the Million Veterans Program$0
I01 · FY2024 · VA · contact PI
CHANGING THE NATURAL HISTORY OF TYPE 2 DIABETES â âCHANGEâ STUDY$300,593
R01 · FY2023 · DK · contact PI
Diabetic Complications and Genetic Variants in the Million Veterans Program$0
I01 · FY2023 · VA · contact PI
Diabetic Complications and Genetic Variants in the Million Veterans Program$0
I01 · FY2023 · VA · contact PI
Assessing Barriers and Facilitators for Participating Structured Lifestyle Intervention and its Real-world Effectiveness and Cost-Effectiveness among US Veterans$570,000
U18 · FY2022 · DP
CHANGING THE NATURAL HISTORY OF TYPE 2 DIABETES â âCHANGEâ STUDY$363,619
R01 · FY2022 · DK · contact PI
Diabetic Complications and Genetic Variants in the Million Veterans Program$0
I01 · FY2022 · VA · contact PI
CHANGING THE NATURAL HISTORY OF TYPE 2 DIABETES â âCHANGEâ STUDY$379,479
R01 · FY2021 · DK · contact PI
Diabetic Complications and Genetic Variants in the Million Veterans Program$0
I01 · FY2021 · VA · contact PI
Diabetic Complications and Genetic Variants in the Million Veterans Program$0
I01 · FY2021 · VA · contact PI
Diabetic Complications and Genetic Variants in the Million Veterans Program$0
I01 · FY2020 · VA · contact PI
Diabetic Complications and Genetic Variants in the Million Veterans Program$0
I01 · FY2019 · VA · contact PI
Reach, Outcomes and System Impacts of the VA's National Weight Loss Program, MOVE$160,250
R21 · FY2015 · DK · contact PI
Reach, Outcomes and System Impacts of the VA's National Weight Loss Program, MOVE$160,250
R21 · FY2014 · DK · contact PI
Screening for IGT: Glucose Challenge vs Predictive Model$681,653
R18 · FY2007 · DK · contact PI
SCREENING FOR IGT$94,555
M01 · FY2007 · RR · contact PI
SCREENING FOR IMPAIRED GLUCOSE TOLERANCE (IGT)$62,726
M01 · FY2007 · RR · contact PI
PREDICTIVE HEALTH: PROSPECTIVE BIOMARKER ASSESSMENT OF METABOLIC AND VASCULAR$6,716
M01 · FY2007 · RR · contact PI
STEROID TIMING AND RENAL TRANSPLANATION (START) STUDY$3,089
M01 · FY2007 · RR · contact PI
PREDICTIVE HEALTH - PROSPECTIVE BIOMARKER ASSESSMENT OF METABOLIC & VASCULAR RIS$673
M01 · FY2007 · RR · contact PI
Screening for IGT: Glucose Challenge vs Predictive Model$720,635
R18 · FY2006 · DK · contact PI
SCREENING FOR IGT$149,102
M01 · FY2006 · RR · contact PI
SCREENING FOR IMPAIRED GLUCOSE TOLERANCE (IGT)$112,057
M01 · FY2006 · RR · contact PI
Screening for IGT: Glucose Challenge vs Predictive Model$723,379
R18 · FY2005 · DK
Screening for IGT: Glucose Challenge vs Predictive Model$98,904
R18 · FY2005 · DK
SIGT STUDY$263
M01 · FY2005 · RR
Screening for IGT: Glucose Challenge vs Predictive Model$716,314
R18 · FY2004 · DK
Screening For Impaired Glucose Tolerance (IGT)$713
M01 · FY2004 · RR
HYPOPITUITARY CONTROL &COMPLICATIONS--HYPOCCS 1$293,069
M01 · FY2002 · RR
HYPOPITUITARY CONTROL &COMPLICATIONS--HYPOCCS 1$293,069
M01 · FY2002 · RR
ENDOCRINOLOGY, METABOLISM AND DIABETES$218,806
T32 · FY2002 · DK
GROWTH HORMONE DEFICIENT ADULTS--IFG1 DOSE REGIMEN$0
M01 · FY2002 · RR
GROWTH HORMONE DEFICIENT ADULTS--IFG1 DOSE REGIMEN$0
M01 · FY2002 · RR
HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY$0
M01 · FY2002 · RR
HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY$0
M01 · FY2002 · RR
HYPOPITUITARY CONTROL &COMPLICATIONS--HYPOCCS 1$293,069
M01 · FY2001 · RR
ENDOCRINOLOGY, METABOLISM AND DIABETES$190,357
T32 · FY2001 · DK
ENDOCRINOLOGY, METABOLISM AND DIABETES$3,551
T32 · FY2001 · DK
IMPROVING PRIMARY CARE OF AFRICAN AMERICANS WITH NIDDM$0
R01 · FY2001 · HS
GROWTH HORMONE DEFICIENT ADULTS--IFG1 DOSE REGIMEN$0
M01 · FY2001 · RR
HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY$0
M01 · FY2001 · RR
ENDOCRINOLOGY, METABOLISM AND DIABETES$160,331
T32 · FY2000 · DK
IMPROVING PRIMARY CARE OF AFRICAN AMERICANS WITH NIDDM$0
R01 · FY2000 · HS